Theraclone Publications

Media professionals who wish to learn more about Theraclone’s technology and areas of research and development, please contact us at:

media@theraclone-sciences.com
206.805.1600

Access the latest clinical data and research findings published by Theraclone and our clinical partners.

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Journal: Science. 2009 Sept 3. [Epub ahead of print]
Authors: Walker LM, Phogat SK, Chan-Hui PY et al.